Interleukin-17: Could it be a key player in COVID-19 infection severity?
fathy, F., Elsheshtawy, N., Moneer, M., hosny, A., Abd Elgawad, M., Abdelhamid, A. (2023). Interleukin-17: Could it be a key player in COVID-19 infection severity?. EKB Journal Management System, 4(1), 36-43. doi: 10.21608/mid.2022.166373.1390
fatma el zahraa Y. fathy; Nadia M. Elsheshtawy; Mayada Moneer; Amr hosny; Marwa Abd Elazeem Abd Elgawad; Amira E. Abdelhamid. "Interleukin-17: Could it be a key player in COVID-19 infection severity?". EKB Journal Management System, 4, 1, 2023, 36-43. doi: 10.21608/mid.2022.166373.1390
fathy, F., Elsheshtawy, N., Moneer, M., hosny, A., Abd Elgawad, M., Abdelhamid, A. (2023). 'Interleukin-17: Could it be a key player in COVID-19 infection severity?', EKB Journal Management System, 4(1), pp. 36-43. doi: 10.21608/mid.2022.166373.1390
fathy, F., Elsheshtawy, N., Moneer, M., hosny, A., Abd Elgawad, M., Abdelhamid, A. Interleukin-17: Could it be a key player in COVID-19 infection severity?. EKB Journal Management System, 2023; 4(1): 36-43. doi: 10.21608/mid.2022.166373.1390

Interleukin-17: Could it be a key player in COVID-19 infection severity?

Microbes and Infectious Diseases
Article 7, Volume 4, Issue 1, February 2023, Page 36-43  XML PDF (487.59 K)
Document Type: Original Article
DOI: 10.21608/mid.2022.166373.1390
View on SCiNiTO View on SCiNiTO
Authors
fatma el zahraa Y. fathy email orcid 1; Nadia M. Elsheshtawyorcid 1; Mayada Moneerorcid 2; Amr hosny3; Marwa Abd Elazeem Abd Elgawad4; Amira E. Abdelhamid1
1Medical Microbiology & Immunology Department, Faculty of Medicine, Ain Shams University
2Department of internal medicine, Faculty of Medicine, Ain Shams University
3Department of Anaesthesia and Intensive care , Faculty of Medicine, Ain Shams University
4Geriatrics medicine and gerontology department , Faculty of Medicine, Ain Shams University
Abstract
Background: Exaggerated cytokines response with release of proinflammatory cytokines i.e., cytokine storm has been described with COVID-19 infection. This cytokine storm plays an important role in lung injury and development of acute respiratory distress syndrome (ARDS) in severely ill patients. One important cytokine that participates in the cytokine storm is interleukin (IL) -17. Aim of the study: Assess serum levels of IL-17 in COVID-19 patients and its correlation with disease severity. Methods:  Sixty-six COVID-19 infected patients (33 moderate cases and 33 severe cases) and 20 healthy controls (HCs) were included in the study. Serum IL-17 level was assessed by ELISA in patients and HCs. Results: IL-17 levels were remarkably higher in patients' groups compared to HCs and also there was statistically significant difference between the patients’ subgroups (p < /em><0.0001). IL-17 was correlated with different laboratory and clinical parameters. At a cut-off value of >25 ng/ml, IL-17 was able to differentiate between the patients’ groups and HCs with 93.94% sensitivity and 65% specificity. Conclusion: Serum IL-17 level correlates to more severe disease courses in COVID 19 patients. Higher levels were associated with devastating outcomes.
Keywords
Interleukin-17; COVID-19; cytokines; disease severity; ICU
Statistics
Article View: 368
PDF Download: 213